Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
24 studies found for:    Reye's Syndrome

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting Intracranial Hypertension and Optic Nerve Sheath Diameter
Conditions: Cerebral Stroke;   Cerebral Venous Thrombosis
Intervention: Other: ONSD ultrasound
2 Completed Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women
Conditions: Pregestational Obesity (BMI > 27kg/m2);   History of Polycystic Ovary Syndrome
Interventions: Drug: medical nutrition therapy + metformin;   Behavioral: Medical nutrition therapy
3 Recruiting Restless Leg Syndrome and Severe Preeclampsia
Conditions: Restless Leg Syndrome;   Severe Preeclampsia
Intervention:
4 Recruiting Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: Belimumab;   Drug: Rituximab;   Drug: Placebo belimumab;   Drug: Placebo rituximab
5 Completed Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge
Conditions: ACS;   Acute Coronary Syndrome;   Myocardial Infarction;   Unstable Angina;   Coronary Artery Disease
Intervention:
6 Terminated
Has Results 		Phase III Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Interventions: Drug: Apixaban;   Drug: Placebo
7 Recruiting ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab
Condition: Acute Coronary Syndrome
Interventions: Drug: alirocumab;   Drug: Placebo
8 Completed Amniotic Fluid Optical Density Determination as a Test for Assessment of Fetal Lung Maturity.
Condition: Respiratory Distress Syndrome, Newborn
Intervention: Procedure: Preterm fetus
9 Completed The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Condition: Acute Coronary Syndrome
Interventions: Drug: Darapladib 160 mg;   Drug: Placebo;   Other: Standard Therapy
10 Completed Colloids in Severe Trauma
Conditions: Abdominal Hypertension;   Abdominal Compartment Syndrome;   Severe Trauma
Intervention: Drug: tetrastarch (Voluven)
11 Completed A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Aleglitazar;   Drug: Placebo
12 Terminated L-Arginine and Antioxidant Vitamins During Pregnancy to Reduce Preeclampsia
Condition: Pre-Eclampsia
Interventions: Procedure: L-arginine supplementation in a medical food;   Procedure: Vitamin C and E supplementation in a medical food
13 Unknown † PI Vs. NNRTI Based Therapy for HIV Advanced Disease
Condition: Acquired Immunodeficiency Syndrome
Interventions: Drug: zidovudine+lamivudine+lopinavir/ritonavir;   Drug: zidovudine + lamivudine + efavirenz
14 Completed Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)
Condition: Prostatic Cancer
Intervention:
15 Not yet recruiting Antiphospholipid Antibodies and Fetal Growth Restriction
Conditions: Fetal Growth Restriction;   Antiphospholipid Syndrome
Intervention:
16 Not yet recruiting Antiphospholipid Antibodies and Early Severe Preeclampsia.
Conditions: Severe Preeclampsia;   Antiphospholipid Syndrome
Intervention:
17 Unknown † 6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome
Condition: Multiple Organ Dysfunction Syndrome
Intervention: Drug: 6-methyl-prednisolone
18 Completed
Has Results 		Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
Conditions: Myocardial Infarction;   Cardiovascular Death;   Atherothrombosis;   Stroke
Interventions: Drug: Ticagrelor 90 mg;   Drug: Ticagrelor 60 mg;   Drug: Ticagrelor Placebo
19 Recruiting Omega 3 Polyunsaturated Fatty Acids (PUFA) or Magnesium in Obese Polycystic Ovary Syndrome Patients
Conditions: Polycystic Ovary Syndrome;   Obesity
Interventions: Drug: Metformin;   Dietary Supplement: Magnesium;   Dietary Supplement: PUFA
20 Terminated Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment
Conditions: HIV;   AIDS;   Tuberculosis
Interventions: Drug: Simultaneous ARV and antiMTB;   Drug: Deferred RV and antiMTB treatment
To Top

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
† Indicates status has not been verified in more than two years